SCHEMBL6357972

SCHEMBL6357972

NC(=O)N(c1ccc(Oc2ccccc2)cc1)c1ccc2nn(CCNC3CCCC3)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 5/20 0.47
MCHR2 Q969V1 2/20 0.45
BTK Q06187 2/20 0.38
PKM P14618 1/20 0.37
LMNA P02545 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
ALDH1A1 P00352 3/20 0.35
EPHX1 P07099 1/20 0.35
F10 P00742 1/20 0.35
HCK P08631 1/20 0.34
FLT3 P36888 1/20 0.34
KDM4E B2RXH2 3/20 0.34
KMT2A Q03164 2/20 0.34
F2 P00734 1/20 0.34
PLG P00747 1/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
ST14 Q9Y5Y6 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5862152 0.99 MCHR1 (0.47) MCHR1MCHR2BTKPKMLMNA
SCHEMBL6348132 0.93 MCHR1 (0.45) MCHR1MCHR2BTKPKMLMNA
SCHEMBL6380408 0.82 MCHR1 (0.64) MCHR1MCHR2ALDH1A1KMT2AMEN1
SCHEMBL5860816 0.81 MCHR1 (0.71) MCHR1MCHR2EPHX1
SCHEMBL5861903 0.81 MCHR1 (0.70) MCHR1MCHR2LMNAEPHX1
SCHEMBL5860819 0.80 MCHR1 (0.68) MCHR1MCHR2BTKLMNAALDH1A1
SCHEMBL5860936 0.78 MCHR1 (0.41) MCHR1BTKALDH1A1KDM4ESMN1; SMN2
SCHEMBL6374843 0.77 NPSR1 (0.45) MCHR1BTKLMNAALDH1A1KDM4E
SCHEMBL5862038 0.76 MCHR1 (0.64) MCHR1MCHR2EPHX1
SCHEMBL5860855 0.73 ALDH1A1 (0.41) MCHR1MCHR2BTKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885MCHR2 2/4885BTK 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.